Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to target cancers, enhance maternal and fetal health, and fight periodontal disease, as well as for daily health. Its flagship product is ProJuvenol, a synergistic blend of complex anti-aging ingredients based upon pterostilbene to promote cellular rejuvenation and healthy functionality. The company also focuses on the manufacture of an oral device to treat patients with obstructive sleep apnea. Therapeutic Solutions International, Inc. was founded in 2010 and is based in Oceanside, California.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Phone(760) 295-7208
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees3
Next Earnings DateN/A
OptionableNot Optionable
Therapeutic Solutions International (OTCMKTS:TSOI) Frequently Asked Questions
What is Therapeutic Solutions International's stock symbol?
Therapeutic Solutions International trades on the OTCMKTS under the ticker symbol "TSOI."
Has Therapeutic Solutions International been receiving favorable news coverage?
News headlines about TSOI stock have trended somewhat negative this week, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Therapeutic Solutions International earned a news sentiment score of -1.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days.
Who are some of Therapeutic Solutions International's key competitors?
Some companies that are related to Therapeutic Solutions International include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Almirall (LBTSF), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Biocure Technology (CURE), Canada House Wellness Group (CHV), Cannabics Pharmaceuticals (CNBX), CannaRoyalty (ORHOF), Cardiome Pharma (COM), China Longyi Group Int'l (CGYG), Creative Medical Technology (CELZ) and Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (CYCCP).
What other stocks do shareholders of Therapeutic Solutions International own?
Who are Therapeutic Solutions International's key executives?
Therapeutic Solutions International's management team includes the folowing people:
- Mr. Timothy George Dixon, Chairman, CEO & Pres (Age 61)
- Mr. Gerry B. Berg, VP, CFO & Director (Age 72)
- Dr. Hong Ma, Chief Science Officer (Age 50)
- Dr. James Drew Veltmeyer, Chief Medical Officer & Member of Scientific Advisory Board
How do I buy shares of Therapeutic Solutions International?
Shares of TSOI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Therapeutic Solutions International's stock price today?
One share of TSOI stock can currently be purchased for approximately $0.0034.
What is Therapeutic Solutions International's official website?
How can I contact Therapeutic Solutions International?
Therapeutic Solutions International's mailing address is 4093 Oceanside Blvd Ste B, OCEANSIDE, CA 92056-5816, United States. The company can be reached via phone at (760) 295-7208.
MarketBeat Community Rating for Therapeutic Solutions International (OTCMKTS TSOI)
MarketBeat's community ratings are surveys of what our community members think about Therapeutic Solutions International and other stocks. Vote "Outperform" if you believe TSOI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TSOI will underperform the S&P 500 over the long term. You may vote once every thirty days.
